Viemed Healthcare, Inc. (VMD)

Name: Viemed Healthcare, Inc. (VMD) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name VIEMED HEALTHCARE, INC. · CIK 0001729149 · Nasdaq · Services-Misc Health & Allied Services, NEC

Sector Services
Fiscal year ends Dec 31

For the year ended 2025-12-31, Viemed Healthcare, Inc. reported revenue of $270.28M. Revenue grew 20.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $301.61M.

Key ratios (year ended 2025-12-31)

57.5%

Gross margin

8.5%

Operating margin

5.5%

Net margin

10.6%

Return on year-end equity

20.5%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-08-20

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31
Revenue	$301.61M	$270.28M	$224.26M	$183.01M	$138.83M	$117.06M	$131.31M	$80.26M	n/a	n/a	n/a
Cost of Revenue	$128.28M	$114.82M	$91.05M	$70.22M	$54.15M	$43.65M	$51.20M	$24.25M	n/a	n/a	n/a
Gross Profit	$173.32M	$155.46M	$133.20M	$112.78M	$84.68M	$73.41M	$80.11M	$56.01M	n/a	n/a	n/a
R&D Expense	$2.46M	$3.02M	$3.07M	$2.78M	$2.70M	$2.11M	$1.08M	$848.0K	n/a	n/a	n/a
Operating Income	$22.77M	$22.95M	$17.90M	$14.33M	$8.25M	$11.58M	$26.78M	$8.86M	n/a	n/a	n/a
Depreciation & Amortization	$30.25M	$28.61M	$25.37M	$21.86M	$15.63M	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA	$53.02M	$51.56M	$43.27M	$36.19M	$23.88M	n/a	n/a	n/a	n/a	n/a	n/a
Net Income	$14.50M	$14.93M	$11.27M	$10.24M	$6.22M	$9.13M	$31.53M	$8.53M	n/a	n/a	n/a
EPS (Diluted)	n/a	$0.37	$0.28	$0.25	$0.16	$0.22	$0.78	$0.21	n/a	n/a	n/a
Total Assets	$204.22M	$199.15M	$177.07M	$154.90M	$117.04M	$117.96M	$112.56M	$82.60M	$79.98M	$71.01M	$58.72M
Total Liabilities	$58.26M	$55.63M	$43.77M	$41.00M	$19.95M	$23.14M	$30.87M	$38.90M	$39.66M	$34.88M	$24.83M
Shareholders' Equity	$144.03M	$141.54M	$131.39M	$113.89M	$97.09M	$94.82M	$81.69M	$43.70M	$40.32M	$36.14M	$33.89M
Cash & Equivalents	$10.68M	$13.50M	$17.54M	$12.84M	$16.91M	$28.41M	$30.98M	$13.36M	$12.63M	$7.69M	$7.41M
Operating Cash Flow	$60.78M	$51.92M	$39.09M	$45.21M	$27.75M	$22.49M	$35.11M	$19.09M	n/a	n/a	n/a
Capital Expenditures	$31.55M	$39.98M	$37.77M	$26.09M	$22.90M	$19.74M	$13.04M	$13.38M	n/a	n/a	n/a
Free Cash Flow	$29.24M	$11.93M	$1.32M	$19.12M	$4.85M	$2.75M	$22.07M	$5.70M	n/a	n/a	n/a
Share Repurchases	$18.32M	$13.22M	$0	$0	$9.57M	$0	$0	$1.52M	n/a	n/a	n/a
Shares Outstanding	38.09M	38.02M	39.13M	38.51M	38.05M	39.64M	39.19M	37.95M	n/a	n/a	n/a
Weighted Average Diluted Shares	n/a	40.82M	40.81M	40.38M	39.81M	40.68M	40.53M	39.75M	n/a	n/a	n/a
EPS (Basic)	n/a	$0.38	$0.29	$0.27	$0.16	$0.23	$0.81	$0.23	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView